Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Seroprevalence of SARS-CoV-2 significantly varies with age: preliminary results from a mass population screening

View ORCID ProfileGabriele Pagani, Federico Conti, View ORCID ProfileAndrea Giacomelli, Dario Bernacchia, Rossana Rondanin, Andrea Prina, Vittore Scolari, Cecilia Eugenia Gandolfi, Silvana Castaldi, Giuseppe Marano, Cosimo Ottomano, Patrizia Boracchi, Elia Biganzoli, Massimo Galli
doi: https://doi.org/10.1101/2020.06.24.20138875
Gabriele Pagani
1Università degli Studi di Milano, Italy
2ASST FBF-Sacco, Milano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gabriele Pagani
  • For correspondence: gabriele.pagani@unimi.it
Federico Conti
1Università degli Studi di Milano, Italy
2ASST FBF-Sacco, Milano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Giacomelli
1Università degli Studi di Milano, Italy
2ASST FBF-Sacco, Milano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrea Giacomelli
Dario Bernacchia
1Università degli Studi di Milano, Italy
2ASST FBF-Sacco, Milano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rossana Rondanin
3Medispa s.r.l
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Prina
3Medispa s.r.l
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vittore Scolari
4Sorbonne Université, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia Eugenia Gandolfi
1Università degli Studi di Milano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silvana Castaldi
1Università degli Studi di Milano, Italy
5Fondazione IRCCS Ca’ Granda Ospedale Maggiore policlinico di Milano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giuseppe Marano
1Università degli Studi di Milano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cosimo Ottomano
6Synlab s.p.a
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrizia Boracchi
1Università degli Studi di Milano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elia Biganzoli
1Università degli Studi di Milano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Massimo Galli
1Università degli Studi di Milano, Italy
2ASST FBF-Sacco, Milano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives Castiglione D’Adda is one of the municipalities more precociously and severely affected by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) epidemic in Lombardy. With our study we aimed to understand the diffusion of the infection by mass seroprevalence screening.

Methods We searched for SARS-CoV-2 IgGs in the entire voluntary population using lateral flow immune-cromatographic tests on capillary blood (rapid tests). We then performed chemioluminescent serological assays (CLIA) and naso-pharyngeal swabs in a randomized representative sample of 562 subjects and in every subject with a positive rapid test.

Results Based on CLIA serologies on the representative random sample (509 subjects), we estimated a 23% IgG seroprevalence. We also found a strong correlation between age and prevalence, with the elderly showing the highest probability of a positive serological test.

Conclusions In an area of unrestricted viral circulation less than one-fourth of the population tested positive for SARS-CoV-2 IgG. Seroprevalence increased with increasing age, possibly suggesting differences in susceptibility to the infection.

Introduction

Coronavirus Induced Disease 2019 (COVID-19) is caused by a novel betacoronavirus which was first identified in China and denominated SARS-CoV-2 (Severe Acute Respiratory Sindrome Coronavirus 2) [1]. Italy was the first European country that suffered a wide spread of the infection, which caused hundreds of thousands of cases [2].

The municipality of Castiglione d’Adda, a rural town of about 4550 inhabitants located South-East of Milan, has been heavily affected by SARS-CoV-2 infection since the earliest stages of the epidemic and subjected to movement restrictions since February 23rd, 2020. As of June 21, 2020, 184 confirmed cases of COVID-19 were reported, the large majority of which requiring hospitalization, accounting for about 4% of the total population. At the same time, 47 deaths were officially attributed to COVID-19. During the epidemic, testing was restricted to severely symptomatic cases. Consequently, the true extent of the SARS-CoV-2 infection remains unknown.

Methods

In this study, the entire population of Castiglione D’Adda was invited to perform a lateral-flow immunocromatographic tests on capillary blood (Prima Lab, Switzerland) from the 18th of May to the 7th of June. News about the mass screening was disseminated by the town municipality. A random sample of 562 subjects (stratified per sex and age) was invited to undergo confirmatory tests by chemiluminescent method on venipuncture drawn blood (CLIA, IgG anti-SARS-CoV-2, Abbott, USA) and SARS-CoV-2 PCR on NPS, regardless of RICT results. More detailed information about the randomization procedure and the study design are available on the complete protocol, published on MedXriv pre-print server [3].

The analysis of IgG prevalence in the different age groups was performed by logistic regression models with response variable equal to 1 for positive IgG results, and 0 for negative IgG results. Age and gender were included as independent variables. Results were reported in terms of estimated probabilities of being positive to IgG test as a function of age, with respective 95% confidence intervals.

Results

Results presented in this paper are based on 509 people selected in the random sample who agreed to undergo venipuncture to perform CLIA serologies. Characteristics of the selected population are reported in Table 1A.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1A: Characteristics of 509 subjects in the random sample

Numerical variables are presented as means.

CAD: Coronary Artery Disease; MI: Miocardial Infarction; COPD: Chronic Obstructive Pulmonary Disease;

The overall seroprevalence found in the tested sample was 22.6% (95% confidence interval 17.2%- 29.1%). Interestingly, seroprevalence increases with increasing age (Table 1B).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Tab.1B IgG positivity per age group

In multivariate analyses, a significant effect of age was found (p<0.0001) while no significant association emerged between IgG positivity and gender (p=0.2560). The possible existence of a non-linear effect of age was tested by including spline polynomials, without significant results (p=0.9078). Furthermore, an age/gender interaction effect did not result significant (p=0.5199). Estimates of probabilities of being positive to IgG test, from a model including only age as independent variable, are reported in Fig.1.

Fig.1:
  • Download figure
  • Open in new tab
Fig.1: Estimated probability of IgG positivity as a function of age

Solid line: estimates, dashed lines: 95% confidence intervals.

Discussion

Since the early phases of the pandemic, advanced age was identified as an independent predictor for severe disease and worse outcomes [4]. Beside this, it remains unclear if the limited number of cases reported in children [5] is due to a milder course of disease, with a larger percentage of asymptomatic cases, or to a lower susceptibility to infection, as our results seem to suggest. Different ACE2 expression according to age have been postulated to explain clinical expression and susceptibility to the infection. In particular, a higher expression of ACE2 in lung tissues in advanced age groups had been speculated [6, 7]. Moreover, a variable susceptibility to other coronavirus such as HCoV-NL63, which also use ACE2 as cell receptor in humans, in different age groups, has been also reported in different age groups [8].

Another possible explanation may be that an asymptomatic/pauci-symptomatic infection, more common in younger subjects, could elicit a less marked, or transient, antibody response, as already found in the closely related Middle East Respiratory Syndrome Coronavirus (MERS-CoV) [9]. A possible confounding factor in our findings could be related to social distancing measures: schools of any grade were among the first institutions to be closed in Italy, starting from the 5th of March. This could have led to a lower exposure to the infection in children in pre-scholar and scholar age groups.

In conclusion, our findings suggest that IgG seroprevalence for SARS-CoV-2 increases with increasing age and these data suggest a lower susceptibility to infection in the lower age groups. These findings have important implications in epidemiology and public health, particularly in designing future population screenings, and could be an important contribution in the re-opening process, especially considered that more than three-fourths of the population could be still susceptible to SARS-CoV-2 infection, even in an area of initially unrestricted viral circulation.

Data Availability

Complete dataset is available on a reasonable request.

Conflict of interests

The authors declare no conflicts of interest. All authors have seen and approved the final manuscript.

Funding

The study was funded thanks to the non-conditioning economical support from CISOM (Corpo Italiano di Soccorso dell’Ordine di Malta), Banca Mediolanum, Fondazione Rava, Mylan Italia and FC Internazionale Milano.

Ethical approval

The study was approved by University of Milan’s Ethical Committee.

Acknowledgments

MG, GP, FC, DB, AG, RR and EB defined the study protocol. RR, AP, FC, DB and GP cooperated in the practical execution of the study and data gathering. GP drafted a first version of the manuscript, which was then revised and integrated by MG, EB, AG, CEG and SC. CO was responsible of serologies and NPSs execution. EB, PB and GM analyzed the data. All authors approved the final version of the manuscript.

Footnotes

  • An error in the Background section was amended (76 was the number of deaths by any causes, while 47 were the deaths officially attributed to COVID-19). Methods and results sections were updated. Table 1A and 1B were added to show demoographic characteristics and seroprevalence per age-groups.

References

  1. [1].↵
    Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020; 382: 727–733.
    OpenUrlCrossRefPubMed
  2. [2].↵
    EpiCentro. Coronavirus | Istituto Superiore di Sanità, https://www.epicentro.iss.it/coronavirus/ (accessed 29 May 2020).
  3. [3].↵
    Pagani G, Bernacchia D, Conti F, et al. Dynamics of the SARS-CoV-2 epidemic in the earliest-affected areas in Italy: 1 Mass screening for SARS-CoV-2 serological positivity (SARS-2-SCREEN). medRxiv 2020; 2020.06.06.20124081.
  4. [4].↵
    Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet 2020; 395:507–513.
    OpenUrlCrossRef
  5. [5].↵
    Lee P-I, Hu Y-L, Chen P-Y, et al. Are children less susceptible to COVID-19? Journal of Microbiology, Immunology and Infection 2020; 53: 371–372.
    OpenUrl
  6. [6].↵
    Li Y, Zhou W, Yang L, et al. Physiological and pathological regulation of ACE2, the SARS- CoV-2 receptor. Pharmacological Research 2020; 157: 104833.
    OpenUrlCrossRefPubMed
  7. [7].↵
    Bourgonje AR, Abdulle AE, Timens W, et al. Angiotensin-converting enzyme-2 (ACE2), SARS-CoV-2 and pathophysiology of coronavirus disease 2019 (COVID-19). The Journal of Pathology n/a. DOI:10.1002/path.5471.
    OpenUrlCrossRefPubMed
  8. [8].↵
    Huang S-H, Su M-C, Tien N, et al. Epidemiology of human coronavirus NL63 infection among hospitalized patients with pneumonia in Taiwan. Journal of Microbiology Immunology and Infection 2017; 50: 763–770.
    OpenUrl
  9. [9].↵
    Choe PG, Perera RAPM, Park WB, et al. MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015. Emerg Infect Dis 2017; 23: 1079–1084.
    OpenUrlCrossRefPubMed
Back to top
PreviousNext
Posted August 28, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Seroprevalence of SARS-CoV-2 significantly varies with age: preliminary results from a mass population screening
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Seroprevalence of SARS-CoV-2 significantly varies with age: preliminary results from a mass population screening
Gabriele Pagani, Federico Conti, Andrea Giacomelli, Dario Bernacchia, Rossana Rondanin, Andrea Prina, Vittore Scolari, Cecilia Eugenia Gandolfi, Silvana Castaldi, Giuseppe Marano, Cosimo Ottomano, Patrizia Boracchi, Elia Biganzoli, Massimo Galli
medRxiv 2020.06.24.20138875; doi: https://doi.org/10.1101/2020.06.24.20138875
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Seroprevalence of SARS-CoV-2 significantly varies with age: preliminary results from a mass population screening
Gabriele Pagani, Federico Conti, Andrea Giacomelli, Dario Bernacchia, Rossana Rondanin, Andrea Prina, Vittore Scolari, Cecilia Eugenia Gandolfi, Silvana Castaldi, Giuseppe Marano, Cosimo Ottomano, Patrizia Boracchi, Elia Biganzoli, Massimo Galli
medRxiv 2020.06.24.20138875; doi: https://doi.org/10.1101/2020.06.24.20138875

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1101)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9785)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2319)
  • Geriatric Medicine (223)
  • Health Economics (463)
  • Health Informatics (1563)
  • Health Policy (737)
  • Health Systems and Quality Improvement (606)
  • Hematology (238)
  • HIV/AIDS (507)
  • Infectious Diseases (except HIV/AIDS) (11657)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (240)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2149)
  • Nursing (134)
  • Nutrition (338)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1183)
  • Ophthalmology (366)
  • Orthopedics (129)
  • Otolaryngology (220)
  • Pain Medicine (148)
  • Palliative Medicine (50)
  • Pathology (313)
  • Pediatrics (698)
  • Pharmacology and Therapeutics (302)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2188)
  • Public and Global Health (4674)
  • Radiology and Imaging (781)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)